BEVERLY HILLS, Calif., Sept. 13, 2012 /PRNewswire/ -- Eaton Scientific Systems, Ltd. ("Eaton" or the "Company") a wholly-owned subsidiary of Pristine Solutions, Inc. (OTCQB: PRTN) is pleased to announce that it has entered into a wide-reaching Consulting Agreement with Dr. Jennifer Berman, MD (the "Agreement"). Under terms of the Agreement, Dr. Berman has agreed to provide the Company with her frontline insight into the current state of women's health care and in particular the menopause, peri-menopause, and post-menopause treatment marketplace. Dr. Berman has also agreed to be an advocate of Tropine 3, and to organize and participate in select media interviews and other public relations opportunities (television, radio, print, etc.) advocating the benefits of Tropine 3 as an effective non-hormonal treatment for hot flashes.
"We are very excited and honored to have someone of Dr. Berman's stature, expertise, and dedication to women's health related issues and issues relating to menopause that are the impetus behind Eaton Scientific's development of Tropine 3," stated Michael Borkowski, CEO of Eaton Scientific. "Dr. Berman is one of the country's foremost experts on issues related to menopause as it relates to sexual health. Her prominence and name recognition amongst women within the Tropine 3 target market will be a significant benefit to the Company as we proceed with our planned clinic trials and marketing efforts."
Jennifer R. Berman, MD, is an urologist and an internationally renowned expert and pioneer in the field of female urology and female sexual medicine. In 2001, Dr. Berman co-founded the Female Sexual Medicine Center at University of California, Los Angeles (UCLA). She serves as director of female urology and sexual medicine at the Rodeo Drive Women's Health Center and operates the Berman Women's Wellness Center in Beverly Hills, CA.
In addition to her on going medical practice, Dr. Berman previously co-hosted, with her sister Laura Berman, PhD, the popular television series on Discovery Health Network, Berman and Berman. Considered a leading expert on women's sexual health, she has appeared on national television, in print, and on radio shows. She appears regularly on Good Morning America and has been featured on The Oprah Winfrey Show, CNN's Larry King Live, 48 Hours, NBC Nightly News, 20/20, MSNBC, Lifetime Television, America's Health Network, New York Times Magazine, Newsweek, Fortune and others.
She is also the co-author of the best-selling book "For Women Only: A Revolutionary Guide to Overcoming Sexual Dysfunction and Reclaiming Your Sex Life," and her most recent title, "Secrets of the Sexually Satisfied Woman: Ten Keys to Unlocking Ultimate Pleasure."
An author of numerous scientific publications for peer-reviewed journals as well as several chapters on female sexual dysfunction, Dr. Berman has lectured worldwide. She has also made significant scientific contributions in the advancement of female sexual health. For two consecutive years, she was awarded the Pfizer Scholar in Urology Award and has repeatedly been recognized with awards and honors at local, national, and international scientific meetings. Dr. Berman is a principle investigator and consultant to pharmaceutical companies, assisting the development of therapies for female sexual dysfunction.
She is a member of the editorial board of several scientific journals and is a fellow of the American Urological Association and a member of American Medical Association, the Sexual Medicine Society of North America, the International Society for the Study of Women's Sexual Health, and the Society for the Study of Impotence Research.
Dr. Berman received her medical degree from Boston University School of Medicine. She completed her post-graduate urology residency training at the University of Maryland and received specialized fellowship training in female urology and female pelvic floor reconstructive surgery at UCLA Medical Center.
In her personal life, Dr. Berman is dedicated to increasing community awareness about women's health issues. She has been the recipient of numerous prestigious awards and honors including Israel Cancer Research Fund's Women of Action Award, The National Association of Women Business Owners Rising Star of the Year Award and the Los Angeles Business Journal's Women Who Make a Difference Award.
About Pristine Solutions, Inc.
Pristine Solutions, Inc., through its wholly-owned subsidiary company, Eaton Scientific Systems, Ltd., holds the intellectual property and global marketing rights to Tropine 3, a patent pending novel indication of an existing FDA approved drug for the non-hormonal treatment of hot flashes in pre-menopausal, peri- menopausal, and post-menopausal women.
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Pristine Solutions' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Pristine Solutions' filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Pristine Solutions herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Pristine Solutions disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
|SOURCE Eaton Scientific Systems, Ltd.|
Copyright©2012 PR Newswire.
All rights reserved